Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	319.24	205.33	48.98
Graham Fair Price	-41.70	4.98	8.54
PEG	54.40	-0.80	-1.76
Price/Book	-24.56	1.51	2.01
Price/Cash Flow	66.06	-19.28	-56.82
Prices/Earnings	124.94	52.65	23.41
Price/Sales	26.08	30.78	24.41
Price/FCF	66.06	-19.28	-56.82
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.06	0.47	0.48
Operating Margin	-58.58	0.16	0.38
ROA	-67.76	< 0.005	0.02
ROE	0.02	< 0.005	-66.46
ROIC	0.02	< 0.005	-72.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.77	0.93	-16.80
Dividends QOQ	0.30	4.51	1412.03
EBIT QOQ	0.41	-0.75	83.96
EPS QOQ	-0.13	-0.66	-393.27
FCF QOQ	0.31	-1.24	292.58
Revenue QOQ	0.06	-0.40	539.44
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	78.17	149.84	91.69
Days Sales Outstanding (DSO)	19.58	20.62	5.31
Inventory Turnover	1.15	0.60	-47.83
Debt/Capitalization	0.08	0.14	66.97
Quick Ratio	0.43	0.33	-22.85
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12.30	12.38	0.66
Cash	0.83	0.62	-25.21
Capex	-0.80	-0.89	-11.20
Free Cash Flow	-0.43	-0.97	-123.76
Revenue	1.01	0.61	-39.77
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.64	0.68	4.80
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.62	14.37	2226.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating